Genentech initiated another round of layoffs affecting its workforce. Three Vice Presidents were among the casualties in this latest reduction. This action is part of a restructuring within the Genentech Research and Early Development (gRED) group. The company is shutting down its physiological chemistry and infectious disease units. Genentech stated these adjustments ensure investments align with core therapeutic areas and portfolio priorities.
South San Francisco, California
https://www.fiercebiotech.com/biotech/genentech-executes-another-round-layoffs-3-vps-axed